Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Significance levels for stability pooling test: a simulation study.

Wen-Jen Chen1, Yi Tsong

  • 1Division of Biometrics II, HFD-715, Center for Drug Evaluation and Research, FDA, Rockville, Maryland 20857, USA. chenw@cder.fda.gov

Journal of Biopharmaceutical Statistics
|August 19, 2003
PubMed
Summary

Determining drug product shelf life requires careful analysis of stability data. This study introduces an algorithm to reduce false pooling of batch data, improving the accuracy of shelf-life decisions and controlling Type-I error rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same author

Statistical approaches for shelf-life determination of a drug product.

Journal of biopharmaceutical statistics·2026
Same author

Parallelism of four-parameter logistic bioassay models: equivalence testing for parameter differences.

Journal of biopharmaceutical statistics·2026
Same author

A survey of parallelism testing methods for bioassays.

Journal of biopharmaceutical statistics·2026
Same author

A multivariate equivalence test based on Mahalanobis distance with a data-driven margin.

Journal of biopharmaceutical statistics·2026
Same author

Sample size for confidence intervals for percentiles and application to cut-point determination.

Journal of biopharmaceutical statistics·2026

Area of Science:

  • Pharmaceutical Sciences
  • Biostatistics
  • Drug Development

Background:

  • Drug product shelf life is critical for ensuring identity, strength, quality, and purity.
  • New Drug Application (NDA) stability studies evaluate evidence to support proposed shelf lives.
  • Current practices may involve pooling batch data, which can lead to inaccuracies.

Purpose of the Study:

  • To develop and evaluate an algorithm to reduce false pooling of batch slopes or intercepts in stability studies.
  • To minimize false positive rates in approving proposed drug product shelf lives.
  • To maintain prespecified Type-I error rates (5% or 10%) in shelf-life decisions.

Main Methods:

  • Utilized simulation techniques to test the proposed algorithm.
  • Focused on analyzing slope and intercept differences between batches.

Related Experiment Videos

  • Evaluated the algorithm's effectiveness in reducing false pooling rates.

    • Main Results:

    • The proposed algorithm demonstrated a reduction in false pooling rates.
    • This reduction in false pooling contributes to lowering false positive rates in shelf-life approval decisions.
    • The algorithm helps maintain the desired Type-I error rate.

    Conclusions:

    • The developed algorithm offers a more reliable method for analyzing drug product stability data.
    • Accurate shelf-life determination is enhanced by minimizing erroneous data pooling.
    • This approach supports robust decision-making in the new drug application process.